Biochemistry of Mitochondrial Coenzyme Q Biosynthesis

Trends in Biochemical Sciences

Volumn 42, Issue 10, 2017, Pages 824-843

  Stefely, Jonathan A ^a,b,c   Pagliarini, David J ^a,b  

^a MORGRIDGE INSTITUTE FOR RESEARCH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

biosynthesis; coenzyme Q; complex Q; CoQ synthome; lipids; metabolon; mitochondria; mitochondrial disease; oxidative phosphorylation; protein complex; ubiquinone

Indexed keywords

COENZYME Q11P; COENZYME Q4; COENZYME Q5; COENZYME Q6; COENZYME Q7; COENZYME Q8; COENZYME Q9; UBIDECARENONE; UBIQUINONE; UNCLASSIFIED DRUG;

BIOCHEMISTRY; DEHYDROGENATION; GENOMICS; HUMAN; HYDROXYLATION; LIPID ANALYSIS; LIPID METABOLISM; LIPID TRANSPORT; LIPIDOMICS; LIPOGENESIS; METABOLOMICS; METHYLATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TRANSAMINATION; TRANSCRIPTOMICS; BIOSYNTHESIS; METABOLISM;

HUMANS; MITOCHONDRIA; UBIQUINONE;

EID: 85029526365     PISSN: 09680004     EISSN: 13624326     Source Type: Journal    
DOI: 10.1016/j.tibs.2017.06.008     Document Type: Review

References (188)

1. Crane, F.L., et al. Isolation of a quinone from beef heart mitochondria. Biochim. Biophys. Acta 25 (1957), 220–221.
2. Morton, R.A., Ubiquinone. Nature 182 (1958), 1764–1767.
3. Lester, R.L., et al. Coenzyme Q: a new group of quinones. J. Am. Chem. Soc. 80 (1958), 4751–4752.
4. Wolf, D.E., Coenzyme Q. I. Structure Studies on the Coenzyme Q Group. J. Am. Chem. Soc., 80, 1958, 4752.
5. Mitchell, P., Protonmotive redox mechanism of the cytochrome b-c1 complex in the respiratory chain: protonmotive ubiquinone cycle. FEBS Lett. 56 (1975), 1–6.
6. Lester, R.L., Crane, F.L., The natural occurrence of coenzyme Q and related compounds. J. Biol. Chem. 234 (1959), 2169–2175.
7. Jones, M.E., Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis. Annu. Rev. Biochem. 49 (1980), 253–279.
8. Frerman, F.E., Acyl-CoA dehydrogenases, electron transfer flavoprotein and electron transfer flavoprotein dehydrogenase. Biochem. Soc. Trans. 16 (1988), 416–418.
9. Echtay, K.S., et al. Coenzyme Q is an obligatory cofactor for uncoupling protein function. Nature 408 (2000), 609–613.
10. Fontaine, E., et al. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J. Biol. Chem. 273 (1998), 25734–25740.
11. Sastry, S.P., et al. Distribution of coenzyme Q in rat liver cell fractions. Nature, 189, 1961, 577.
12. Do, T.Q., et al. Enhanced sensitivity of ubiquinone-deficient mutants of Saccharomyces cerevisiae to products of autoxidized polyunsaturated fatty acids. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 7534–7539.
13. Stocker, R., et al. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc. Natl. Acad. Sci. U. S. A. 88 (1991), 1646–1650.
14. Frei, B., et al. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc. Natl. Acad. Sci. U. S. A. 87 (1990), 4879–4883.
15. Sevin, D.C., Sauer, U., Ubiquinone accumulation improves osmotic-stress tolerance in Escherichia coli. Nat. Chem. Biol. 10 (2014), 266–272.
16. Petrillo, E., et al. A chloroplast retrograde signal regulates nuclear alternative splicing. Science 344 (2014), 427–430.
17. Kalen, A., et al. Age-related changes in the lipid compositions of rat and human tissues. Lipids 24 (1989), 579–584.
18. Lakowski, B., Hekimi, S., Determination of life-span in Caenorhabditis elegans by four clock genes. Science 272 (1996), 1010–1013.
19. Ewbank, J.J., et al. Structural and functional conservation of the Caenorhabditis elegans timing gene clk-1. Science 275 (1997), 980–983.
20. Larsen, P.L., Clarke, C.F., Extension of life-span in Caenorhabditis elegans by a diet lacking coenzyme Q. Science 295 (2002), 120–123.
21. Liu, J.-L., et al. A single biochemical activity underlies the pleiotropy of the aging-related protein CLK-1. Sci. Rep., 7, 2017, 859.
22. Liu, X., et al. Evolutionary conservation of the clk-1-dependent mechanism of longevity: loss of mclk1 increases cellular fitness and lifespan in mice. Genes Dev. 19 (2005), 2424–2434.
23. Wang, Y., Hekimi, S., Understanding ubiquinone. Trends Cell Biol. 26 (2016), 367–378.
24. Miles, M.V., The uptake and distribution of coenzyme Q10. Mitochondrion 7 (2007), S72–S77.
25. Momose, K., Rudney, H., 3-Polyprenyl-4-hydroxybenzoate synthesis in the inner membrane of mitochondria from p-hydroxybenzoate and isopentenylpyrophosphate. A demonstration of isoprenoid synthesis in rat liver mitochondria. J. Biol. Chem. 247 (1972), 3930–3940.
26. Kalen, A., et al. Nonaprenyl-4-hydroxybenzoate transferase, an enzyme involved in ubiquinone biosynthesis, in the endoplasmic reticulum-Golgi system of rat liver. J. Biol. Chem. 265 (1990), 1158–1164.
27. Kalen, A., et al. Ubiquinone biosynthesis by the microsomal fraction from rat liver. Biochim. Biophys. Acta 926 (1987), 70–78.
28. Mugoni, V., et al. Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis. Cell 152 (2013), 504–518.
29. Clarke, C.F., New advances in coenzyme Q biosynthesis. Protoplasma 213 (2000), 134–147.
30. Aussel, L., et al. Biosynthesis and physiology of coenzyme Q in bacteria. Biochim. Biophys. Acta 1837 (2014), 1004–1011.
31. Bentley, R.R., et al. The origin of the benzoquinone ring of coenzyme Q9 in the rat. Biochem. Biophys. Res. Commun. 5 (1961), 443–446.
32. Olson, R.E., et al. Benzoate derivatives as intermediates in the biosynthesis of coenzyme Q in the rat. J. Biol. Chem. 238 (1963), 3146–3148.
33. Booth, A.N., et al. Urinary phenolic acid metabolites of tyrosine. J. Biol. Chem. 235 (1960), 2649–2652.
34. Payet, L.A., et al. Mechanistic details of early steps in coenzyme Q biosynthesis pathway in yeast. Cell Chem. Biol. 23 (2016), 1241–1250.
35. Gibson, M.I., et al. The branch point in the biosynthesis of the aromatic amino-acids. Nature 195 (1962), 1173–1175.
36. Morgan, P.N., et al. Conversion of shikimic acid to aromatic compounds. Nature 194 (1962), 1239–1241.
37. Cox, G.B., Gibson, F., Biosynthesis of vitamin K and ubiquinone. Relation to the shikimic acid pathway in Escherichia coli. Biochim. Biophys. Acta 93 (1964), 204–206.
38. Lawrence, J., et al. Biosynthesis of ubiquinone in Escherichia coli K-12: biochemical and genetic characterization of a mutant unable to convert chorismate into 4-hydroxybenzoate. J. Bacteriol. 118 (1974), 41–45.
39. Marbois, B., et al. para-Aminobenzoic acid is a precursor in coenzyme Q6 biosynthesis in Saccharomyces cerevisiae. J. Biol. Chem. 285 (2010), 27827–27838.
40. Pierrel, F., et al. Involvement of mitochondrial ferredoxin and para-aminobenzoic acid in yeast coenzyme Q biosynthesis. Chem. Biol. 17 (2010), 449–459.
41. Enriquez, J.A., et al. Hypothesis driven versus hypothesis-free: filling the gaps in CoQ biosynthesis. Cell Metab. 24 (2016), 525–526.
42. Stefely, J.A., et al. Mitochondrial protein functions elucidated by multi-omic mass spectrometry profiling. Nat. Biotechnol. 34 (2016), 1191–1197.
43. Zahedi, R.P., et al. Proteomic analysis of the yeast mitochondrial outer membrane reveals accumulation of a subclass of preproteins. Mol. Biol. Cell 17 (2006), 1436–1450.
44. Gloor, U., Wiss, O., On the biosynthesis of ubiquinone (50). Arch. Biochem. Biophys. 83 (1959), 216–222.
45. Olson, R.E., et al. Studies on coenzyme Q. Pattern of labeling in coenzyme Q9 after administration of isotopic acetate and aromatic amino acids to rats. J. Biol. Chem. 240 (1965), 514–523.
46. Gold, P.H., Olson, R.E., Studies on coenzyme Q. The biosynthesis of coenzyme Q9 in rat tissue slices. J. Biol. Chem. 241 (1966), 3507–3516.
47. Chaykin, S., et al. Phosphorylated intermediates in the synthesis of squalene. Proc. Natl. Acad. Sci. U. S. A. 44 (1958), 998–1004.
48. Lynen, F.E., et al. Farnesyl-pyrophosphat und 3-Methyl-d3-butenyl-1-pyrophosphat, die biologischen vorstufen des squalens. Angew. Chem. 70 (1958), 738–742.
49. Lynen, F.A., et al. g,g-Dimethyl-allyl-pyrophosphat und geranyl-pyrophosphat, biologische vorstufen des squalens. Angew. Chem. 71 (1959), 657–684.
50. Winrow, M.J., Rudney, H., The incorporation of p-hydroxybenzoic acid and isopentenyl pyrophosphate into ubiquinone precursors by cell-free preparations of rat tissues. Biochem. Biophys. Res. Commun. 37 (1969), 833–840.
51. Casey, J., Threlfall, D.R., Formation of 3-hexaprenyl-4-hydroxybenzoate by matrix-free mitochondrial membrane-rich preparations of yeast. Biochim. Biophys. Acta 530 (1978), 487–502.
52. Tzagoloff, A., et al. Assembly of the mitochondrial membrane system. Characterization of nuclear mutants of Saccharomyces cerevisiae with defects in mitochondrial ATPase and respiratory enzymes. J. Biol. Chem. 250 (1975), 8228–8235.
53. Tzagoloff, A., Dieckmann, C.L., PET genes of Saccharomyces cerevisiae. Microbiol. Rev. 54 (1990), 211–225.
54. Ashby, M.N., Edwards, P.A., Elucidation of the deficiency in two yeast coenzyme Q mutants. Characterization of the structural gene encoding hexaprenyl pyrophosphate synthetase. J. Biol. Chem. 265 (1990), 13157–13164.
55. Ashby, M.N., et al. COQ2 is a candidate for the structural gene encoding para-hydroxybenzoate:polyprenyltransferase. J. Biol. Chem. 267 (1992), 4128–4136.
56. Gin, P., Clarke, C.F., Genetic evidence for a multi-subunit complex in coenzyme Q biosynthesis in yeast and the role of the Coq1 hexaprenyl diphosphate synthase. J. Biol. Chem. 280 (2005), 2676–2681.
57. Pagliarini, D.J., et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134 (2008), 112–123.
58. Rhee, H.W., et al. Proteomic mapping of mitochondria in living cells via spatially restricted enzymatic tagging. Science 339 (2013), 1328–1331.
59. He, C.H., et al. Coenzyme Q supplementation or over-expression of the yeast Coq8 putative kinase stabilizes multi-subunit Coq polypeptide complexes in yeast coq null mutants. Biochim. Biophys. Acta 1841 (2014), 630–644.
60. Okada, K., et al. Polyprenyl diphosphate synthase essentially defines the length of the side chain of ubiquinone. Biochim. Biophys. Acta 1302 (1996), 217–223.
61. Cheng, W., Li, W., Structural insights into ubiquinone biosynthesis in membranes. Science 343 (2014), 878–881.
62. Jackman, L.M., et al. Methionine as the source of methyl groups for ubiquinone and vitamin K: a study using nuclear magnetic resonance and mass spectrometry. Biochim. Biophys. Acta 141 (1967), 1–7.
63. Alexander, K., Young, I.G., Three hydroxylations incorporating molecular oxygen in the aerobic biosynthesis of ubiquinone in Escherichia coli. Biochemistry 17 (1978), 4745–4750.
64. Ozeir, M., et al. Coq6 is responsible for the C4-deamination reaction in coenzyme Q biosynthesis in Saccharomyces cerevisiae. J. Biol. Chem. 290 (2015), 24140–24151.
65. Olsen, R.K., et al. 2-Decaprenylphenol, biosynthetic precursor of ubiquinone-10. J. Am. Chem. Soc. 87 (1965), 2298–2300.
66. Friis, P., et al. Complete sequence of biosynthesis from p-hydroxybenzoic acid to ubiquinone. J. Am. Chem. Soc. 88 (1966), 4754–4756.
67. Olsen, R.K., et al. 2-Multiprenylphenols and 2-decaprenyl-6-methoxyphenol, biosynthetic precursors of ubiquinones. J. Am. Chem. Soc. 88 (1966), 5919–5923.
68. Cox, G.B., et al. Mutant strains of Escherichia coli K-12 unable to form ubiquinone. J. Bacteriol. 95 (1968), 1591–1598.
69. Young, I.G., et al. Pathway for ubiquinone biosynthesis in Escherichia coli K-12: gene-enzyme relationships and intermediates. J. Bacteriol. 114 (1973), 42–52.
70. Goewert, R.R., et al. Identification of 3,4-dihydroxy-5-hexaprenylbenzoic acid as an intermediate in the biosynthesis of ubiquinone-6 by Saccharomyces cerevisiae. Biochemistry 20 (1981), 4217–4223.
71. Goewert, R.R., et al. Identification of 3-methoxy-4-hydroxy-5-hexaprenylbenzoic acid as a new intermediate in ubiquinone biosynthesis by Saccharomyces cerevisiae. Biochemistry 20 (1981), 5611–5616.
72. Tran, U.C., Clarke, C.F., Endogenous synthesis of coenzyme Q in eukaryotes. Mitochondrion 7 (2007), S62–S71.
73. Hsu, A.Y., et al. Complementation of coq3 mutant yeast by mitochondrial targeting of the Escherichia coli UbiG polypeptide: evidence that UbiG catalyzes both O-methylation steps in ubiquinone biosynthesis. Biochemistry 35 (1996), 9797–9806.
74. Belogrudov, G.I., et al. Yeast COQ4 encodes a mitochondrial protein required for coenzyme Q synthesis. Arch. Biochem. Biophys. 392 (2001), 48–58.
75. Barkovich, R.J., et al. Characterization of the COQ5 gene from Saccharomyces cerevisiae. Evidence for a C-methyltransferase in ubiquinone biosynthesis. J. Biol. Chem. 272 (1997), 9182–9188.
76. Dibrov, E., et al. The COQ5 gene encodes a yeast mitochondrial protein necessary for ubiquinone biosynthesis and the assembly of the respiratory chain. J. Biol. Chem. 272 (1997), 9175–9181.
77. Nguyen, T.P., et al. Molecular characterization of the human COQ5 C-methyltransferase in coenzyme Q10 biosynthesis. Biochim. Biophys. Acta 1841 (2014), 1628–1638.
78. Gin, P., et al. The Saccharomyces cerevisiae COQ6 gene encodes a mitochondrial flavin-dependent monooxygenase required for coenzyme Q biosynthesis. J. Biol. Chem. 278 (2003), 25308–25316.
79. Jonassen, T., et al. Yeast Clk-1 homologue (Coq7/Cat5) is a mitochondrial protein in coenzyme Q synthesis. J. Biol. Chem. 273 (1998), 3351–3357.
80. Do, T.Q., et al. A defect in coenzyme Q biosynthesis is responsible for the respiratory deficiency in Saccharomyces cerevisiae abc1 mutants. J. Biol. Chem. 276 (2001), 18161–18168.
81. Tauche, A., et al. Ubiquinone biosynthesis in Saccharomyces cerevisiae: the molecular organization of O-methylase Coq3p depends on Abc1p/Coq8p. FEMS Yeast Res. 8 (2008), 1263–1275.
82. Xie, L.X., et al. Expression of the human atypical kinase ADCK3 rescues coenzyme Q biosynthesis and phosphorylation of Coq polypeptides in yeast coq8 mutants. Biochim. Biophys. Acta 1811 (2011), 348–360.
83. Johnson, A., et al. COQ9, a new gene required for the biosynthesis of coenzyme Q in Saccharomyces cerevisiae. J. Biol. Chem. 280 (2005), 31397–31404.
84. Hsieh, E.J., et al. Saccharomyces cerevisiae Coq9 polypeptide is a subunit of the mitochondrial coenzyme Q biosynthetic complex. Arch. Biochem. Biophys. 463 (2007), 19–26.
85. Khadria, A.S., et al. A Gly-zipper motif mediates homodimerization of the transmembrane domain of the mitochondrial kinase ADCK3. J. Am. Chem. Soc. 136 (2014), 14068–14077.
86. Stefely, J.A., et al. Mitochondrial ADCK3 employs an atypical protein kinase-like fold to enable coenzyme Q biosynthesis. Mol. Cell 57 (2015), 83–94.
87. Stefely, J.A., et al. Cerebellar ataxia and coenzyme Q deficiency through loss of unorthodox kinase activity. Mol. Cell 63 (2016), 608–620.
88. Monaghan, R.M., et al. A nuclear role for the respiratory enzyme CLK-1 in regulating mitochondrial stress responses and longevity. Nat. Cell Biol. 17 (2015), 782–792.
89. Ozeir, M., et al. Coenzyme Q biosynthesis: Coq6 is required for the C5-hydroxylation reaction and substrate analogs rescue Coq6 deficiency. Chem. Biol. 18 (2011), 1134–1142.
90. Hajj Chehade, M., et al. ubiI, a new gene in Escherichia coli coenzyme Q biosynthesis, is involved in aerobic C5-hydroxylation. J. Biol. Chem. 288 (2013), 20085–20092.
91. Clarke, C.F., et al. Ubiquinone biosynthesis in Saccharomyces cerevisiae. Isolation and sequence of COQ3, the 3,4-dihydroxy-5-hexaprenylbenzoate methyltransferase gene. J. Biol. Chem. 266 (1991), 16636–16644.
92. Jonassen, T., Clarke, C.F., Isolation and functional expression of human COQ3, a gene encoding a methyltransferase required for ubiquinone biosynthesis. J. Biol. Chem. 275 (2000), 12381–12387.
93. Stroobant, P., et al. Mutants of Escherichia coli K-12 blocked in the final reaction of ubiquinone biosynthesis: characterization and genetic analysis. J. Bacteriol. 109 (1972), 134–139.
94. Leppik, R.A., et al. Membrane-associated reactions in ubiquinone biosynthesis. 2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone methyltransferase. Biochim. Biophys. Acta 428 (1976), 146–156.
95. Poon, W.W., et al. Yeast and rat Coq3 and Escherichia coli UbiG polypeptides catalyze both O-methyltransferase steps in coenzyme Q biosynthesis. J. Biol. Chem. 274 (1999), 21665–21672.
96. Cox, G.B., et al. Biosynthesis of ubiquinone in Escherichia coli K-12: location of genes affecting the metabolism of 3-octaprenyl-4-hydroxybenzoic acid and 2-octaprenylphenol. J. Bacteriol. 99 (1969), 450–458.
97. Rudney, H., Parson, W.W., The conversion of p-hydroxybenzaldehyde to the benzoquinone ring of ubiquinone in Rhodospirillum rubrum. J. Biol. Chem. 238 (1963), 3137–3138.
98. Gulmezian, M., et al. The role of UbiX in Escherichia coli coenzyme Q biosynthesis. Arch. Biochem. Biophys. 467 (2007), 144–153.
99. White, M.D., et al. UbiX is a flavin prenyltransferase required for bacterial ubiquinone biosynthesis. Nature 522 (2015), 502–506.
100. Payne, K.A., et al. New cofactor supports alpha,beta-unsaturated acid decarboxylation via 1,3-dipolar cycloaddition. Nature 522 (2015), 497–501.
101. Clarke, C.F., Allan, C.M., Biochemistry: unexpected role for vitamin B2. Nature 522 (2015), 427–428.
102. Yen, H.C., et al. Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency. Biochim. Biophys. Acta 1860 (2016), 1864–1876.
103. Young, I.G.M., et al. Characterization and genetic analysis of mutant strains of Escherichia coli K-12 accumulating the ubiquinone precursors 2-octaprenyl-6-methoxy-1,4-benzoquinone and 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinone. J. Bacteriol. 105 (1971), 769–778.
104. Lee, P.T., et al. A C-methyltransferase involved in both ubiquinone and menaquinone biosynthesis: isolation and identification of the Escherichia coli ubiE gene. J. Bacteriol. 179 (1997), 1748–1754.
105. Dai, Y.N., et al. Crystal structures and catalytic mechanism of the C-methyltransferase Coq5 provide insights into a key step of the yeast coenzyme Q synthesis pathway. Acta Crystallogr. D Biol. Crystallogr. 70 (2014), 2085–2092.
106. Marbois, B.N., Clarke, C.F., The COQ7 gene encodes a protein in Saccharomyces cerevisiae necessary for ubiquinone biosynthesis. J. Biol. Chem. 271 (1996), 2995–3004.
107. Stenmark, P., et al. A new member of the family of di-iron carboxylate proteins. Coq7 (clk-1), a membrane-bound hydroxylase involved in ubiquinone biosynthesis. J. Biol. Chem. 276 (2001), 33297–33300.
108. Behan, R.K., Lippard, S.J., The aging-associated enzyme CLK-1 is a member of the carboxylate-bridged diiron family of proteins. Biochemistry 49 (2010), 9679–9681.
109. Lu, T.T., et al. Aging-associated enzyme human clock-1: substrate-mediated reduction of the diiron center for 5-demethoxyubiquinone hydroxylation. Biochemistry 52 (2013), 2236–2244.
110. Pelosi, L., et al. Evolution of ubiquinone biosynthesis: multiple proteobacterial enzymes with various regioselectivities to catalyze three contiguous aromatic hydroxylation reactions. mSystems, 1, 2016 e00091-16.
111. Xie, L.X., et al. Overexpression of the Coq8 kinase in Saccharomyces cerevisiae coq null mutants allows for accumulation of diagnostic intermediates of the coenzyme Q6 biosynthetic pathway. J. Biol. Chem. 287 (2012), 23571–23581.
112. Poon, W.W., et al. 3-Hexaprenyl-4-hydroxybenzoic acid forms a predominant intermediate pool in ubiquinone biosynthesis in Saccharomyces cerevisiae. Arch. Biochem. Biophys. 320 (1995), 305–314.
113. Marbois, B., et al. Coq3 and Coq4 define a polypeptide complex in yeast mitochondria for the biosynthesis of coenzyme Q. J. Biol. Chem. 280 (2005), 20231–20238.
114. Tran, U.C., et al. Complementation of Saccharomyces cerevisiae coq7 mutants by mitochondrial targeting of the Escherichia coli UbiF polypeptide: two functions of yeast Coq7 polypeptide in coenzyme Q biosynthesis. J. Biol. Chem. 281 (2006), 16401–16409.
115. Allan, C.M., et al. Identification of Coq11, a new coenzyme Q biosynthetic protein in the CoQ-synthome in Saccharomyces cerevisiae. J. Biol. Chem. 290 (2015), 7517–7534.
116. Lohman, D.C., et al. Mitochondrial COQ9 is a lipid-binding protein that associates with COQ7 to enable coenzyme Q biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E4697–E4705.
117. Floyd, B.J., et al. Mitochondrial protein interaction mapping identifies regulators of respiratory chain function. Mol. Cell 63 (2016), 621–632.
118. Ashraf, S., et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J. Clin. Invest. 123 (2013), 5179–5189.
119. Srere, P.A., The metabolon. Trends Biochem. Sci. 10 (1985), 109–110.
120. Barnes, S.J., Weitzman, P.D., Organization of citric acid cycle enzymes into a multienzyme cluster. FEBS Lett. 201 (1986), 267–270.
121. Pedley, A.M., Benkovic, S.J., A new view into the regulation of purine metabolism: the purinosome. Trends Biochem. Sci. 42 (2017), 141–154.
122. Laursen, T., et al. Characterization of a dynamic metabolon producing the defense compound dhurrin in sorghum. Science 354 (2016), 890–893.
123. Midzak, A., Papadopoulos, V., Adrenal mitochondria and steroidogenesis: from individual proteins to functional protein assemblies. Front. Endocrinol. (Lausanne), 7, 2016, 106.
124. Schmidt, O., et al. Mitochondrial protein import: from proteomics to functional mechanisms. Nat. Rev. Mol. Cell Biol. 11 (2010), 655–667.
125. Gonzalez-Mariscal, I., et al. The regulation of coenzyme q biosynthesis in eukaryotic cells: all that yeast can tell us. Mol. Syndromol. 5 (2014), 107–118.
126. Lapointe, C.P., et al. Post-transcriptional control of coenzyme Q biosynthesis revealed by transomic analysis of the RNA-binding protein Puf3p. bioRxiv, 2017, 146985.
127. Leuenberger, D., et al. Different import pathways through the mitochondrial intermembrane space for inner membrane proteins. EMBO J. 18 (1999), 4816–4822.
128. Jiang, N., et al. Mouse CLK-1 is imported into mitochondria by an unusual process that requires a leader sequence but no membrane potential. J. Biol. Chem. 276 (2001), 29218–29225.
129. Ulrich, E.L., et al. Location and mobility of ubiquinones of different chain lengths in artificial membrane vesicles. Biochemistry 24 (1985), 2501–2508.
130. Metz, G.H., et al. NMR studies of ubiquinone location in oriented model membranes: evidence for a single motionally-averaged population. J. Am. Chem. Soc. 117 (1995), 564–565.
131. Padilla-Lopez, S., et al. Genetic evidence for the requirement of the endocytic pathway in the uptake of coenzyme Q6 in Saccharomyces cerevisiae. Biochim. Biophys. Acta 1788 (2009), 1238–1248.
132. Fernandez-Ayala, D.J., et al. Coenzyme Q. distribution in HL-60 human cells depends on the endomembrane system. Biochim. Biophys. Acta 1713 (2005), 129–137.
133. Marbois, B., et al. The yeast Coq4 polypeptide organizes a mitochondrial protein complex essential for coenzyme Q biosynthesis. Biochim. Biophys. Acta 1791 (2009), 69–75.
134. Leonard, C.J., et al. Novel families of putative protein kinases in bacteria and archaea: evolution of the “eukaryotic” protein kinase superfamily. Genome Res. 8 (1998), 1038–1047.
135. Poon, W.W., et al. Identification of Escherichia coli ubiB, a gene required for the first monooxygenase step in ubiquinone biosynthesis. J. Bacteriol. 182 (2000), 5139–5146.
136. Lagier-Tourenne, C., et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am. J. Hum. Genet. 82 (2008), 661–672.
137. Kannan, N., et al. Structural and functional diversity of the microbial kinome. PLoS Biol., 5, 2007, e17.
138. Reidenbach, A., et al. Conserved lipid and small molecule modulation of COQ8 reveals regulation of the ancient UbiB family. bioRxiv, 2017, 149823.
139. Garcia-Corzo, L., et al. Dysfunctional Coq9 protein causes predominant encephalomyopathy associated with CoQ deficiency. Hum. Mol. Genet. 22 (2013), 1233–1248.
140. He, C.H., et al. Yeast Coq9 controls deamination of coenzyme Q intermediates that derive from para-aminobenzoic acid. Biochim. Biophys. Acta 1851 (2015), 1227–1239.
141. Barros, M.H., et al. The Saccharomyces cerevisiae COQ10 gene encodes a START domain protein required for function of coenzyme Q in respiration. J. Biol. Chem. 280 (2005), 42627–42635.
142. Allan, C.M., et al. A conserved START domain coenzyme Q-binding polypeptide is required for efficient Q biosynthesis, respiratory electron transport, and antioxidant function in Saccharomyces cerevisiae. Biochim. Biophys. Acta 1831 (2013), 776–791.
143. Loiseau, L., et al. The UbiK protein is an accessory factor necessary for bacterial ubiquinone (UQ) biosynthesis and forms a complex with the UQ biogenesis factor UbiJ. J. Biol. Chem., 2017, 10.1074/jbc.M117.789164 Published online May 30, 2017.
144. Aussel, L., et al. ubiJ, a new gene required for aerobic growth and proliferation in macrophage, is involved in coenzyme Q biosynthesis in Escherichia coli and Salmonella enterica serovar Typhimurium. J. Bacteriol. 196 (2014), 70–79.
145. Quinzii, C., et al. A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am. J. Hum. Genet. 78 (2006), 345–349.
146. Jakobs, B.S., et al. A novel mutation in COQ2 leading to fatal infantile multisystem disease. J. Neurol. Sci. 326 (2013), 24–28.
147. Diomedi-Camassei, F., et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J. Am. Soc. Nephrol. 18 (2007), 2773–2780.
148. Desbats, M.A., et al. Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure. Eur. J. Hum. Genet. 23 (2015), 1254–1258.
149. Salviati, L., et al. Haploinsufficiency of COQ4 causes coenzyme Q10 deficiency. J. Med. Genet. 49 (2012), 187–191.
150. Brea-Calvo, G., et al. COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency. Am. J. Hum. Genet. 96 (2015), 309–317.
151. Heeringa, S.F., et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J. Clin. Invest. 121 (2011), 2013–2024.
152. Doimo, M., et al. Effect of vanillic acid on COQ6 mutants identified in patients with coenzyme Q10 deficiency. Biochim. Biophys. Acta 1842 (2014), 1–6.
153. Freyer, C., et al. Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4-dihydroxybensoic acid. J. Med. Genet. 52 (2015), 779–783.
154. Mollet, J., et al. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am. J. Hum. Genet. 82 (2008), 623–630.
155. Liu, Y.T., et al. Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation. J. Neurol. Neurosurg. Psychiatry 85 (2014), 493–498.
156. Blumkin, L., et al. Heterozygous mutations in the ADCK3 gene in siblings with cerebellar atrophy and extreme phenotypic variability. JIMD Rep. 12 (2014), 103–107.
157. Gerards, M., et al. Nonsense mutations in CABC1/ADCK3 cause progressive cerebellar ataxia and atrophy. Mitochondrion 10 (2010), 510–515.
158. Horvath, R., et al. Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3. J. Neurol. Neurosurg. Psychiatry 83 (2012), 174–178.
159. Korkmaz, E., et al. ADCK4-associated glomerulopathy causes adolescence-onset FSGS. J. Am. Soc. Nephrol. 27 (2015), 63–68.
160. Duncan, A.J., et al. A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am. J. Hum. Genet. 84 (2009), 558–566.
161. Danhauser, K., et al. Fatal neonatal encephalopathy and lactic acidosis caused by a homozygous loss-of-function variant in COQ9. Eur. J. Hum. Genet. 24 (2015), 450–454.
162. Mollet, J., et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J. Clin. Invest. 117 (2007), 765–772.
163. Lopez, L.C., et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 79 (2006), 1125–1129.
164. Gasser, D.L., et al. Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10. Am. J. Physiol. Renal Physiol. 305 (2013), F1228–F1238.
165. Gempel, K., et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 130 (2007), 2037–2044.
166. Haas, D., et al. Coenzyme Q(10) is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria. J. Inherit. Metab. Dis. 32 (2009), 570–575.
167. Quinzii, C.M., et al. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64 (2005), 539–541.
168. Aeby, A., et al. Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency. J. Inherit. Metab. Dis., 30, 2007, 827.
169. Marcoff, L., Thompson, P.D., The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J. Am. Coll. Cardiol. 49 (2007), 2231–2237.
170. Kassardjian, C.D., et al. Myopathy during treatment with the antianginal drug ranolazine. J. Neurol. Sci. 347 (2014), 380–382.
171. Emmanuele, V., et al. Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Arch. Neurol. 69 (2012), 978–983.
172. Vafai, S.B., Mootha, V.K., Mitochondrial disorders as windows into an ancient organelle. Nature 491 (2012), 374–383.
173. Montini, G., et al. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N. Engl. J. Med. 358 (2008), 2849–2850.
174. Wang, Y., Hekimi, S., Mitochondrial respiration without ubiquinone biosynthesis. Hum. Mol. Genet. 22 (2013), 4768–4783.
175. +/−mice. J. Cell Biol. 199 (2012), 215–224.
176. Ben-Meir, A., et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell 14 (2015), 887–895.
177. Anderson, C.M., et al. Dependence of brown adipose tissue function on CD36-mediated coenzyme Q uptake. Cell Rep. 10 (2015), 505–515.
178. Bentinger, M., et al. Distribution and breakdown of labeled coenzyme Q10 in rat. Free Radic. Biol. Med. 34 (2003), 563–575.
179. Santos-Ocana, C., et al. Uptake of exogenous coenzyme Q and transport to mitochondria is required for bc1 complex stability in yeast coq mutants. J. Biol. Chem. 277 (2002), 10973–10981.
180. Garcia-Corzo, L., et al. Ubiquinol-10 ameliorates mitochondrial encephalopathy associated with CoQ deficiency. Biochim. Biophys. Acta 1842 (2014), 893–901.
181. Wang, Y., et al. Mitochondrial function and lifespan of mice with controlled ubiquinone biosynthesis. Nat. Commun., 6, 2015, 6393.
182. Luna-Sanchez, M., et al. The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene. EMBO Mol. Med. 7 (2015), 670–687.
183. Parikh, S., et al. Practice patterns of mitochondrial disease physicians in North America Part 2: treatment, care and management. Mitochondrion 13 (2013), 681–687.
184. Parikh, S., et al. A modern approach to the treatment of mitochondrial disease. Curr. Treat. Options Neurol. 11 (2009), 414–430.
185. Chaturvedi, R.K., Beal, M.F., Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases. Mol. Cell. Neurosci. 55 (2013), 101–114.
186. Dumont, M., et al. Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease. J. Alzheimers Dis. 27 (2011), 211–223.
187. Williams, E.G., et al. Systems proteomics of liver mitochondria function. Science, 352, 2016, aad0189.
188. Young, I.G., et al. Biochemical and genetic studies on ubiquinone biosynthesis in Escherichia coli K-12:4-hydroxybenzoate octaprenyltransferase. J. Bacteriol. 110 (1972), 18–25.